Bayer Adalat Supply Limitations Okay To Combat Parallel Imports
Bayer's unilateral limitations on the quantity of Adalat made available to Spanish and French wholesalers did not represent unacceptable collaboration between the manufacturer and its wholesale customers, according to a recent ruling by a European Union court.
You may also be interested in...
Antiviral Drug Products Division Director Heidi Jolson, MD, will take over as acting director of the Office of Review Management on Nov. 6.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials